IGC Pharma, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
IGC Pharma, Inc. and FirstFire Global Opportunities Fund, LLC amended their April 2026 securities purchase agreement on June 18, 2026. The amendment clarified the Issue Date as April 14, 2026 and extended the Maturity Date, all monthly payment dates, and prepayment period ending dates by 6 calendar days each on a promissory note with original principal of $346,910. No material economic changes to the loan structure were disclosed.
Why this rating
Minor administrative amendment to existing $347K debt (1.9% of company's $18.5M market cap). Six-day extension is routine; no economic restructuring or forgiveness disclosed. Boilerplate housekeeping on small financing.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.